Nutex Health, Inc. Quarterly Deferred Tax Assets, Valuation Allowance in USD from Q4 2016 to Q4 2023

Taxonomy & unit
us-gaap: USD
Description
Amount of deferred tax assets for which it is more likely than not that a tax benefit will not be realized.
Summary
Nutex Health, Inc. quarterly Deferred Tax Assets, Valuation Allowance history and growth rate from Q4 2016 to Q4 2023.
  • Nutex Health, Inc. Deferred Tax Assets, Valuation Allowance for the quarter ending December 31, 2023 was $7.48M.
Deferred Tax Assets, Valuation Allowance, Quarterly (USD)
Deferred Tax Assets, Valuation Allowance, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q4 2023 $7.48M Dec 31, 2023 10-K 2024-03-29
Q4 2021 $2.16M +$203K +10.4% Dec 31, 2021 10-K 2022-03-31
Q4 2020 $1.95M +$911K +87.3% Dec 31, 2020 10-K 2022-03-31
Q4 2019 $1.04M +$1.04M Dec 31, 2019 10-K 2021-04-05
Q4 2018 $0 -$2.71M -100% Dec 31, 2018 10-K 2020-05-14
Q4 2017 $2.71M +$1.21M +80.6% Dec 31, 2017 10-K/A 2019-04-17
Q4 2016 $1.5M Dec 31, 2016 10-K 2018-04-17
* An asterisk sign (*) next to the value indicates that the value is likely invalid.